How Methylation Affects BRD7 in Nasopharyngeal Carcinoma
Author Information
Author(s): Liu Huaying, Zhang Liming, Niu Zhaoxia, Zhou Ming, Peng Cong, Li Xiayu, Deng Tan, Shi Lei, Tan Yixin, Li Guiyuan
Primary Institution: Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Changsha, Hunan, PR China
Hypothesis
DNA methylation regulates BRD7 transcription in nasopharyngeal carcinoma cells.
Conclusion
Demethylation of the BRD7 promoter is necessary for its expression, suggesting its potential as a diagnostic marker in nasopharyngeal carcinoma.
Supporting Evidence
- BRD7 expression is significantly lower in nasopharyngeal carcinoma cells compared to normal cells.
- Methylation of the BRD7 promoter was found in 100% of tumor biopsies from NPC patients.
- Treatment with a DNA methylation inhibitor increased BRD7 mRNA levels in NPC cells.
Takeaway
In nasopharyngeal cancer, a gene called BRD7 is turned off because of a process called methylation, but if we stop this process, we can turn the gene back on.
Methodology
The study used methylation-specific PCR, RT-PCR, and luciferase assays to analyze BRD7 expression and methylation status in various cell lines and clinical samples.
Potential Biases
Potential bias in sample selection and the limited diversity of cell lines used.
Limitations
The study primarily focused on a limited number of cell lines and patient samples, which may not represent all cases of nasopharyngeal carcinoma.
Participant Demographics
18 nasopharyngeal carcinoma patients and 16 normal individuals.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website